Brief: Alpine Immune Sciences Reports Fourth Quarter Results
March 23 (Reuters) - Alpine Immune Sciences Inc
ALPN.O :
* ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND
REPORTS
FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
* ALPINE IMMUNE SCIENCES INC-ANTICIPATES YEAR ENDED CASH OF
$273.4
MILLION AS OF DEC 31, SUFFICIENT TO FUND ITS PLANNED OPERATIONS
THROUGH 2025
* ALPINE IMMUNE SCIENCES INC-QTRLY BASIC AND DILUTED NET
LOSS PER
SHARE $0.41
Source text for Eikon: ID:nBw7cxMTna
Further company coverage: ALPN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpine Immune Sciences
See all newsAlpine Immune Sciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Alpine Immune Sciences Q1 EPS USD -0.28 Vs. IBES Estimate USD -0.41
Moves: Lazard hires veteran healthcare dealmaker Colocci as vice chairman
U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse
US STOCKS-S&P 500, Nasdaq end sharply higher on soft inflation data, eyes on earnings